Global Society of Oncology calls for abstract submissions for research that shapes the future of cancer care ahead of Asia Pacific Annual Meeting in Singapore
SINGAPORE, December 4, 2025 /PRNewswire/ — The American Society of Clinical Oncology (ASCO) today launched its call for abstracts for its Breakthrough 2026 meeting, providing researchers from around the world the opportunity to present and discuss their findings with an influential international audience of cancer care professionals in the heart of Asia.
Ahead of the annual conference, held for the first time in Singapore, oncology professionals can submit abstracts to ASCO Breakthrough from today until February 24, 2026 at 11:59 p.m. Eastern Time (12:59 p.m. Singapore Standard Time, February 25, 2026). ASCO Breakthrough will take place June 25-27, 2026, co-hosted by ASCO and the Singapore Society of Oncology, along with other collaborating societies in the Asia-Pacific region.
The meeting provides cancer care professionals with the opportunity to present their research as the global oncology community comes together to explore the latest advances and accelerate progress toward conquering cancer worldwide. Alongside critical dialogues, cancer care professionals will also be able to view their work through the lens of different health systems and patient populations, connecting global science and regional expertise.
Leadership of the ASCO Breakthrough program includes esteemed cancer care professionals from the region, chaired by Dr. Yun Yen, Taipei Medical University, alongside Past President Dr. Melvin Chua, National Cancer Center, Singapore; President-elect, Dr. Roselle De Guzman, Central Manila University; Dr. Eileen Poon, National Cancer Center Singapore and Singapore Society of Oncology, as well as Dr. Jun Ma, Sun Yat-sen University Cancer Center and ASCO Asia-Pacific Regional Council representative.
Submitting an abstract to the meeting means joining a global stage where new science is not just presented, but advanced. Yun Yen, Program Committee Chair, 2026 ASCO Breakthrough.
ASCO accepts abstracts in areas ranging from artificial intelligence and digital technology to breast cancer, central nervous system tumors, developmental therapies and more. Additional subcategories include advanced diseases, antibody-drug conjugates and devices, and inventions.
All accepted abstracts will be published online as part of the Journal of Clinical Oncology supplement. Abstracts of Trials in Progress (TPS) will also be accepted. Professionals from low- and middle-income countries (LMICs) may request a fee waiver at the time of submission.
In 2024, the Breakthrough Congress welcomed 790 experts from more than 35 countries in the Asia-Pacific region and around the world to Yokohama. Registration for ASCO Breakthrough 2026 will open in December 2025.
To submit abstracts and view more registration details, visit: breakthrough.asco.org
About the American Society of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) adheres to the principle that knowledge conquers cancer. In collaboration with the Association for Clinical Oncology, ASCO represents more than 50,000 oncology professionals who care for people with cancer. Through research, education and the promotion of high-quality patient care, ASCO strives to defeat cancer and create a world where cancer is prevented or cured and every survivor is healthy. Conquer Cancer®, the ASCO Foundation, supports ASCO by funding groundbreaking research and education across the entire cancer continuum. Learn more aboutwww.ASCO.org, and follow usFacebook,X,LinkedIn,Instagram, Blue skyAndYouTube.
About the ASCO breakthrough
ASCO Breakthrough is an annual Asia-Pacific oncology meeting offering innovative research and multidisciplinary expert perspectives on the latest scientific discoveries, clinical and technological advances, and therapeutic approaches that are rapidly changing cancer care. Participate in informative sessions, case discussions and abstract presentations, and join a community of like-minded professionals to help beat cancer together.
SOURCE The American Society of Clinical Oncology
